Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents
- PMID: 19106382
- PMCID: PMC2646028
- DOI: 10.2337/dc08-1274
Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents
Abstract
Objective: Impaired glucose tolerance (IGT) is a pre-diabetic state of increasing prevalence among obese adolescents. The purpose of this study was to determine the natural history of progression from normal glucose tolerance (NGT) to IGT in obese adolescents.
Research design and methods: We determined the evolution of beta-cell function, insulin sensitivity (S(I)), and glucose tolerance in a multiethnic group of 60 obese adolescents over the course of approximately 30 months. Each subject underwent three serial 3-h oral glucose tolerance tests. Dynamic, static, and total beta-cell responsivity (Phi(d), Phi(s), and Phi(tot), respectively) and S(i) were assessed by oral C-peptide and glucose minimal models. The disposition index (DI), which adjusts insulin secretion for S(i), was calculated.
Results: At baseline, all 60 subjects had NGT. Seventy-seven percent (46 subjects) maintained NGT over the three testing periods (nonprogressors), whereas 23% (14 subjects) developed IGT over time (progressors). At baseline, percent fat and BMI Z score were comparable between the groups. Fasting plasma glucose, 2-h glucose, glucose area under the curve at 180 min, and Phi(d) were significantly different between the two groups at baseline, whereas S(i) was comparable between the two groups. Over time, although S(i) remained unchanged in nonprogressors, it steadily worsened by approximately 45% (P > 0.04) in progressors. beta-Cell responsivity decreased by 20% in progressors, whereas it remained stable in nonprogressors. The DI showed a progressive decline in progressors compared with a modest improvement in nonprogressors (P = 0.02).
Conclusions: Obese adolescents who progress to IGT may manifest primary defects in beta-cell function. In addition, progressive decline in S(i) further aggravates beta-cell function, contributing to the worsening of glucose intolerance.
Figures
Similar articles
-
Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose.Diabet Med. 2008 Jan;25(1):73-9. doi: 10.1111/j.1464-5491.2007.02329.x. Diabet Med. 2008. PMID: 18199133
-
Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.Endocrine. 2008 Aug-Dec;34(1-3):75-80. doi: 10.1007/s12020-008-9106-6. Epub 2008 Nov 1. Endocrine. 2008. PMID: 18979203
-
Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.Diabetes Care. 2004 Jun;27(6):1439-46. doi: 10.2337/diacare.27.6.1439. Diabetes Care. 2004. PMID: 15161801
-
Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.Diabetes Care. 2006 May;29(5):1130-9. doi: 10.2337/diacare.2951130. Diabetes Care. 2006. PMID: 16644654 Review.
-
Progression of β-cell dysfunction in obese youth.Curr Diab Rep. 2013 Feb;13(1):89-95. doi: 10.1007/s11892-012-0347-7. Curr Diab Rep. 2013. PMID: 23179960 Review.
Cited by
-
Type 2 diabetes: etiology and reversibility.Diabetes Care. 2013 Apr;36(4):1047-55. doi: 10.2337/dc12-1805. Diabetes Care. 2013. PMID: 23520370 Free PMC article. Review. No abstract available.
-
Insulin resistance in type 2 diabetic youth.Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):255-62. doi: 10.1097/MED.0b013e3283557cd5. Curr Opin Endocrinol Diabetes Obes. 2012. PMID: 22732484 Free PMC article. Review.
-
Insulin resistance in children: consensus, perspective, and future directions.J Clin Endocrinol Metab. 2010 Dec;95(12):5189-98. doi: 10.1210/jc.2010-1047. Epub 2010 Sep 8. J Clin Endocrinol Metab. 2010. PMID: 20829185 Free PMC article.
-
Longitudinal association between adiposity measures and regression of prediabetes/diabetes.Nutr Metab Cardiovasc Dis. 2021 Oct 28;31(11):3085-3094. doi: 10.1016/j.numecd.2021.07.005. Epub 2021 Jul 31. Nutr Metab Cardiovasc Dis. 2021. PMID: 34629252 Free PMC article.
-
Lipotoxicity and β-Cell Failure in Type 2 Diabetes: Oxidative Stress Linked to NADPH Oxidase and ER Stress.Cells. 2021 Nov 26;10(12):3328. doi: 10.3390/cells10123328. Cells. 2021. PMID: 34943836 Free PMC article. Review.
References
-
- Festa A, Williams K, D'Agostino R Jr, Wagenknecht LE, Haffner SM: The natural course of β-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 55:1114–1120, 2006 - PubMed
-
- Weir GC, Bonner-Weir S: Five stages of evolving β-cell dysfunction during progression to diabetes. Diabetes 53 (Suppl. 3):S16–S21, 2004 - PubMed
-
- Weyer C, Tataranni PA, Bogardus C, Pratley RE: Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24:89–94, 2001 - PubMed
-
- Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273:1855–1861, 1995 - PubMed
-
- Steppel JH, Horton ES: Beta-cell failure in the pathogenesis of type 2 diabetes mellitus. Curr Diab Rep 4:169–175, 2004 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical